Petros Pharmaceuticals, Inc.
PTPI
$0.0275
-$0.0005-1.79%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.32M | -14.42M | -14.32M | -4.73M | -7.06M |
| Total Depreciation and Amortization | 1.44M | 1.44M | 1.44M | 1.61M | 1.70M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -928.90K | 7.02M | 7.26M | -5.24M | -3.66M |
| Change in Net Operating Assets | 3.34M | 2.84M | 3.02M | 2.53M | -81.10K |
| Cash from Operations | -4.47M | -3.13M | -2.60M | -5.83M | -9.10M |
| Capital Expenditure | -24.50K | -24.50K | -24.50K | -19.10K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -24.50K | -24.50K | -24.50K | -19.10K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -385.50K | -385.50K | -385.50K | -759.70K | -742.80K |
| Issuance of Common Stock | 8.71M | 8.71M | -- | 0.00 | 15.00M |
| Repurchase of Common Stock | -204.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -3.76M | -5.11M | -6.23M | -7.09M | -4.70M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -379.80K | -379.80K | -379.80K | -379.80K |
| Cash from Financing | 4.36M | 2.83M | -7.00M | -8.23M | 9.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -138.50K | -323.80K | -9.63M | -14.08M | 75.20K |